ADVM Adverum Biotechnologies Inc

Adverum Biotechnologies Inc is a gene therapy company committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye.

$1.18
As of 07/01/2022     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/31/2014
Outstanding shares:  98,770,349
Average volume:  1,556,306
Market cap:   $118,524,419
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BD6NXD7

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.41
PS ratio:   0.00
Return on equity:   -54.78%
Net income %:   0.00%